Triglycerides can indeed be too low, and the consequences extend well beyond what most people expect. While public health messaging focuses almost entirely on the dangers of high triglycerides, research from the past two decades has linked very low levels to a higher risk of hemorrhagic stroke, worse outcomes in heart failure, neurological damage from fat-soluble vitamin deficiency, and even complications during pregnancy. The causes range from rare genetic conditions to advanced liver disease to aggressive lipid-lowering therapy, and the clinical picture differs depending on why the levels dropped.
What Triglycerides Actually Do
Triglycerides are the body’s primary form of stored and transported fat. They shuttle fatty acids through the bloodstream and into cells, where those fatty acids get burned for energy or tucked away for later use. This sounds mundane, but the process is critical: the cycle of building and breaking down triglycerides in fat tissue and muscle ensures that fuel remains available between meals and during fasting.1Trends in Endocrinology & Metabolism. Can Triglycerides Be Too Low? Causes and Risks The liver is central to this operation, assembling triglyceride-rich particles that carry fat to tissues throughout the body.2Comprehensive Physiology. Triglyceride Metabolism in the Liver
Beyond energy transport, triglyceride-rich lipoproteins serve as vehicles for fat-soluble vitamins (A, D, E, and K) and essential fatty acids. When triglyceride levels drop to near zero, those delivery systems break down. That is why extremely low triglycerides are not simply the mirror image of extremely high triglycerides. High levels cause problems through inflammation and plaque buildup; very low levels cause problems through nutrient deprivation and structural deficits in cell membranes.
How Low Is Too Low
Standard lipid panels consider fasting triglycerides below 150 mg/dL (1.7 mmol/L) “normal” and below 100 mg/dL “optimal.” Most clinical guidelines stop there, treating lower as better without qualification. But population studies suggest the relationship between triglyceride levels and health outcomes is not a straight downhill slope. In patients with heart failure, researchers found a U-shaped curve: mortality risk was lowest when triglycerides sat between roughly 105 and 265 mg/dL (1.2 to 3.0 mmol/L), with the sweet spot near 170 mg/dL (1.95 mmol/L). Below about 105 mg/dL, the risk of dying started climbing again.3PubMed Central. Triglyceride levels and its association with all-cause mortality and cardiovascular outcomes among patients with heart failure
That U-shaped pattern does not prove that low triglycerides directly cause harm in every population. In heart failure specifically, very low triglycerides may reflect severe illness, poor nutrition, or a catabolic state rather than acting as an independent killer. But the finding does challenge the assumption that triglycerides in the 30s or 40s are inherently reassuring. Context matters: a lean, healthy marathoner with triglycerides of 45 mg/dL is not in the same situation as a patient with advanced liver disease whose triglycerides have collapsed to 40 mg/dL.
Genetic Conditions That Drive Triglycerides Near Zero
The most dramatic cases of low triglycerides come from inherited disorders. Abetalipoproteinemia is a rare condition caused by mutations in the MTTP gene, which encodes a protein the body needs to package triglycerides into lipoprotein particles for transport. Without functioning microsomal triglyceride transfer protein, the liver and intestine cannot assemble the lipoproteins (VLDL and chylomicrons) that normally carry fat through the bloodstream.4PubMed. A tale of 2 cousins: An atypical and a typical case of abetalipoproteinemia The result is near-zero plasma triglycerides alongside extremely low LDL cholesterol and apolipoprotein B.5PubMed. Abetalipoproteinemia
People with abetalipoproteinemia typically develop symptoms in infancy or early childhood. Because dietary fat cannot be absorbed properly, they experience diarrhea, failure to thrive, and severe deficiencies of fat-soluble vitamins. Animal studies have confirmed how fundamental this pathway is: knocking out the same gene in mice proved lethal for embryos that inherited two copies of the mutation.6PubMed. Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes
A different genetic route to very low triglycerides involves loss-of-function mutations in the ANGPTL3 gene, which causes a condition called familial combined hypolipidemia. People with these mutations have markedly reduced levels of all major lipoproteins, including triglyceride-rich particles and HDL.7PubMed Central. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia Affected family members show the protein is essentially absent from their plasma.8PubMed. Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3
Interestingly, ANGPTL3 loss-of-function carriers appear to enjoy a lower risk of cardiovascular disease, which is one reason pharmaceutical companies are now developing drugs that mimic this genetic effect.9PubMed Central. Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease The distinction is important: not all causes of very low triglycerides carry the same risks. Losing triglycerides because a gene variant reduces lipoprotein production across the board while preserving vitamin absorption appears much safer than losing them because the gut cannot absorb dietary fat at all.
Acquired Causes of Very Low Triglycerides
Outside of rare genetic disorders, the most common reasons for abnormally low triglycerides are conditions that impair the liver’s ability to produce lipoproteins, extreme dietary restriction, hyperthyroidism, and certain medications.
Advanced liver cirrhosis is a well-documented cause. As liver function deteriorates, the organ loses its capacity to synthesize fatty acids and assemble them into triglycerides for export.10PubMed Central. The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins In decompensated cirrhosis, lipoprotein levels progressively fall, and those dropping lipid levels are themselves associated with worse prognosis.11PubMed. Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance Here, low triglycerides are less a standalone problem than a marker of how badly the liver is failing.
Malabsorption syndromes from conditions such as celiac disease, chronic pancreatitis, or inflammatory bowel disease can also drive triglycerides down by starving the body of dietary fat. Severe caloric restriction or eating disorders produce a similar effect. Hyperthyroidism accelerates fat metabolism so aggressively that triglyceride levels may fall well below normal ranges. And aggressive lipid-lowering therapy, particularly newer agents targeting apolipoprotein C-III, can produce large triglyceride reductions. In clinical trials of one such antisense therapy, triglyceride levels dropped by as much as about 70% from baseline.12PubMed. Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia For patients starting from extremely high levels, those reductions bring them into healthy territory. For patients who were only moderately elevated to begin with, the same drug class could, in theory, push triglycerides into ranges where the U-shaped mortality curve begins to matter.
The Link to Hemorrhagic Stroke
One of the most consistent and concerning findings in the research on low triglycerides is an association with bleeding in the brain. Several large studies have reported that people in the lowest range of triglycerides face a higher risk of hemorrhagic stroke compared to those with moderate or even slightly elevated levels.
In the Rotterdam Study, a population-based cohort in the Netherlands, triglyceride levels were strongly and inversely associated with intracerebral hemorrhage. People in the highest triglyceride quartile had roughly an 80% lower risk compared to those in the lowest quartile, and this held after accounting for HDL, LDL, and other risk factors. The same low-triglyceride group also showed more deep brain microbleeds on MRI.13PubMed. Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam Study
The Three-City Study in France found that triglyceride levels at or below roughly 83 mg/dL (0.94 mmol/L) were tied to about twice the risk of hemorrhagic stroke compared to higher levels.14PubMed. Triglycerides and risk of hemorrhagic stroke vs. ischemic vascular events: The Three-City Study And in a large prospective study of women in the United States, those in the lowest quartile of triglycerides had double the risk of hemorrhagic stroke compared to women in the top quartile.15PubMed Central. Lipid levels and the risk of hemorrhagic stroke among women
The proposed mechanism is that very low lipid levels may weaken the walls of small blood vessels in the brain. Cholesterol and other lipids are structural components of cell membranes, and there is biological plausibility to the idea that chronically depleted lipids could compromise vessel integrity. However, this remains partly speculative, and some researchers suspect the association is driven by confounders like alcohol use, liver disease, or malnutrition rather than a direct causal link. What the evidence does make clear is that the pattern shows up across multiple countries, in both men and women, and specifically for hemorrhagic stroke rather than the ischemic kind. That specificity lends it some credibility.
Neurological Damage From Fat-Soluble Vitamin Deficiency
When triglycerides are extremely low because the body cannot properly absorb or transport dietary fat, one of the most serious downstream consequences is deficiency of fat-soluble vitamins, particularly vitamin E. This is the hallmark complication of abetalipoproteinemia, but it can also occur in severe malabsorption from other causes.
Vitamin E deficiency produces a distinctive neurological syndrome. Early symptoms include loss of vibration and position sense, followed by difficulty coordinating movements, reduced reflexes, and progressive damage to the spinal cord and peripheral nerves.16PubMed Central. Sensory Axonopathy Associated With Vitamin E Deficiency If left untreated, severe chronic vitamin E deficiency can progress to a debilitating neurological condition involving ataxia and vision loss.17PubMed. Vitamin E and neurological function: lessons from patients with abetalipoproteinaemia
This is why early diagnosis and high-dose vitamin E supplementation are critical in abetalipoproteinemia. Patients who begin vitamin E replacement therapy in childhood can avoid many of the neurological complications. Without it, the progressive nerve damage is difficult or impossible to reverse. The lesson extends beyond rare genetic conditions: anyone with persistently very low triglycerides and evidence of fat malabsorption should have their fat-soluble vitamin levels checked.
Low Triglycerides and Immune Complications During Cancer Treatment
A newer and somewhat surprising finding concerns patients receiving immune checkpoint inhibitors, a class of cancer drugs that unleash the immune system to attack tumors. Researchers found that patients with low triglyceride levels at the start of treatment had an increased risk of immune-related adverse events, the sometimes severe autoimmune reactions that are a known side effect of these drugs.18PubMed Central. Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitors
The exact mechanism is still being worked out, but lipids play roles in immune cell signaling and membrane composition that go beyond simple energy storage. It is possible that reduced triglyceride levels alter the behavior of T-cells or other immune cells in ways that make autoimmune overreaction more likely. This area of research is young, and it would be premature to call low triglycerides a definitive risk factor for immunotherapy complications. But for oncologists weighing the risk of immune-related side effects, baseline lipid levels may become one more piece of the puzzle.
Pregnancy and Fetal Growth
Triglyceride levels naturally rise during pregnancy, and that increase serves an important purpose: the growing fetus depends on maternal lipid transport for calories and for building blocks like essential fatty acids. When maternal triglycerides are unusually low early in pregnancy, there appear to be consequences for the baby’s growth.
In one study tracking mothers from early pregnancy through the first year of the child’s life, babies born to mothers in the lowest triglyceride quintile were smaller in weight, length, and body mass at birth compared to those born to mothers with higher levels. These smaller infants then showed accelerated “catch-up” growth over their first six months, a pattern that itself has been associated with metabolic risk later in life. About a quarter of infants in the lowest maternal triglyceride group showed this accelerated growth pattern, compared to roughly a fifth of infants in the other groups.19The Journal of Pediatrics. Early Maternal Lipid Profile, Birth Weight, and Postnatal Growth
This does not mean pregnant women should aim for high triglycerides, which carry their own risks including gestational diabetes and preeclampsia. But it does suggest that the normal pregnancy-related rise in triglycerides is not just a metabolic side effect — it is functional, and suppressing it too aggressively could have downstream consequences for fetal nutrition.
Low Triglycerides and Mental Health
A smaller but persistent thread in the research ties low lipid levels, including low triglycerides, to depression and anxiety. In a study of healthy young women, lower triglyceride levels were associated with higher scores on measures of trait depression and anxiety.20Psychosomatic Medicine. Relations of Trait Depression and Anxiety to Low Lipid and Lipoprotein Concentrations in Healthy Young Adult Women Similar patterns have been observed for total cholesterol and LDL.
The biological plausibility here is less clear-cut than for stroke or vitamin deficiency. One hypothesis involves serotonin: cholesterol influences serotonin receptor function, and reduced lipid availability could alter neurotransmitter signaling. Another possibility is that the association runs in the other direction, where depression-related changes in appetite, activity, and cortisol levels drive lipid levels down. Either way, the association is modest and should not be interpreted as proof that having low triglycerides will cause depression. It is better understood as a signal that extremely low lipid levels are not biologically inert and may intersect with mood regulation in ways we do not fully understand yet.
Low Triglycerides in Critical Illness
In intensive care settings, lipid levels frequently plummet during acute illness, and some researchers have tried to figure out whether low triglycerides during sepsis predict worse survival. The evidence here is mixed. A systematic review pooling data from 15 studies found no clear association between admission triglyceride levels and mortality in critically ill sepsis patients.21PubMed Central. Association Between Hypocholesterolemia and Mortality in Critically Ill Patients With Sepsis: A Systematic Review and Meta-Analysis However, at least one individual study found that survivors of ICU sepsis had higher average triglyceride levels than non-survivors, suggesting that low triglycerides during acute infection may signal a worse trajectory.22Archives of Clinical Infectious Diseases. Relationship Between Lipid Profile and Sepsis Outcome in Intensive Care Unit
The difficulty with all critical-care lipid research is the same one that haunts the heart failure data: are low triglycerides causing harm, or are they simply a marker of how sick someone already is? During severe infection, the body’s inflammatory response suppresses lipoprotein production and increases lipid consumption. A patient with triglycerides of 50 mg/dL during septic shock may not be suffering from low triglycerides per se — their low triglycerides may just be telling you that their body is under enormous metabolic stress. Disentangling cause from marker remains one of the harder problems in this field.
When to Actually Worry
For most people who see a low triglyceride number on a routine blood panel, the answer is straightforward: if you feel healthy, eat a normal diet, have no signs of malabsorption, and are not on aggressive lipid-lowering therapy, triglycerides in the range of 40 to 80 mg/dL are unlikely to cause problems. Very fit, lean individuals who eat low-carbohydrate diets commonly land in this range without any underlying pathology.
The situations that warrant closer attention include:
- Triglycerides below 30 mg/dL: At this level, genetic causes like abetalipoproteinemia or familial combined hypolipidemia should be considered, especially if LDL and HDL are also unusually low.
- Fat-soluble vitamin deficiency: If low triglycerides coincide with symptoms like night vision problems, easy bruising, neurological changes, or bone pain, check levels of vitamins A, D, E, and K.
- Unintentional weight loss or chronic diarrhea: These suggest malabsorption, and the low triglycerides are a downstream clue rather than the primary problem.
- Advanced liver disease: Falling triglycerides in a patient with known cirrhosis may indicate worsening liver function.
- Pregnancy: Unusually low triglycerides early in pregnancy deserve monitoring, given the association with lower birth weight.
If you are on medication designed to lower triglycerides and your levels have dropped below the range your doctor targeted, it is worth a conversation about whether the dose needs adjustment. This applies not only to fibrates and fish oil but also to newer agents targeting apolipoprotein C-III or ANGPTL3. These drugs are powerful, and the clinical trials that proved their effectiveness were mostly conducted in people with sky-high triglycerides. How far to push levels down in someone who started closer to normal is a question that clinical guidelines have not fully addressed yet.